Service Agreement - Department of Health Tasmania: 2018, Healthcare associated staphylococcus aureus (including MRSA) bacteraemia infection rate, 2018
Identifying and definitional attributes
|Metadata item type:||Indicator|
|Short name:||Healthcare associated staphylococcus aureus (including MRSA) bacteraemia (rate)|
|Registration status:||Tasmanian Health, Endorsed 28/03/2019|
This indicator measures the rate of Healthcare Associated Staphylococcus aureus bacteraemia infection. This indicator is concerned with cases of this infection which are associated with a patient receiving healthcare.
Staphylococcus aureus bacteraemia (SAB) in Tasmania is a notifiable disease pursuant to the Public Health Act 1997. Mortality of Staphylococcus aureus bacteraemia is around 25-35%. All States have agreed to monitor this infection from a Safety & Quality perspective.
|Indicator set:||Service Plan - Department of Health Tasmania: 2018 Tasmanian Health, Endorsed 28/03/2019|
Collection and usage attributes
The definitions applied are consistent with national definitions which are published by the Australian Commission on Safety and Quality in Healthcare Data set specification – Surveillance of Healthcare Associated Infections: Staphylococcus aureus bacteraemia and Clostridium difficile infection (Version 4.0).
100 x (Numerator ÷ Denominator)
Number of cases of healthcare associated Staphylococcus aureus bacteraemia
Number of patient days for the given period (matching the numerator period)
|Unit of measure:||Disease type|
2018-19 Service Agreement